The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma
Official Title: A Phase II, Multicenter, Single-Arm, Open-Label Study To Evaluate The Safety And Efficacy Of Single-Agent Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma
Study ID: NCT00413036
Brief Summary: Subjects who qualify will receive oral lenalidomide daily on days 1-21 of every 28 day cycle. Treatment will continue until disease progression, or unacceptable adverse events develop
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Northwest Alabama Cancer Center, PC, Muscle Shoals, Alabama, United States
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
Lalita Pandit, MD, Inc, Fountain Valley, California, United States
Access Clinical Research, Rancho Mirage, California, United States
Kaiser Permanente Medical Group, San Diego, California, United States
Pasco Hernando Oncology Associates, Brooksville, Florida, United States
Sylvester Cancer Center/ Univeristy of Miami, Miami, Florida, United States
Hematology Oncology Associates of Central Brevard, Rockledge, Florida, United States
Palm Beach Cancer Institute, West Palm Beach, Florida, United States
Cancer Care Center, Inc., New Albany, Indiana, United States
Ochsner Clinic Foundation, Baton Rouge, Louisiana, United States
Michigan Hematology and Oncology Institute, Southgate, Michigan, United States
Mayo Clinic, Rochester, Minnesota, United States
University of Nebraska, Omaha, Nebraska, United States
Center for Cancer and Hematologic Disease, Cherry Hill, New Jersey, United States
Our Lady of Mercy Cancer Center, Bronx, New York, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
HIllman Cancer Center -UPMC, Pittsburg, Pennsylvania, United States
Palmetto Hematology Oncology, Spartanburg, South Carolina, United States
Family Cancer Center, Collierville, Tennessee, United States
London Health Science Center, London, Ontario, Canada
Saskatoon Cancer Center, Saskatoon, Saskatchewan, Canada
Toronto Sunnybrook Regional Cancer Centre, Toronto, , Canada
Service d'Hématologie Clinique, Créteil, , France
Clinical Haematology Department, Dijon, , France
Institute Paoli-Calmettes Départmentd 'Hématologie, Marseille, , France
CHU Hopital Lapeyronie, Hematologie et Oncologie Medicale, Montpellier, , France
Hopital Saint Louis Service d'Hémato-Oncologie, Paris, , France
Hopital du Haut-Lévèque, Pessac, , France
Centre Hospitalier Lyon Sud, Hematologie Clinique, Pierre Bénite, , France
Department d'Hématologie Centre Henri Becquerel, Rouen, , France
Research Site, Berlin, , Germany
Universitaetsklinikum Essen, Essen, , Germany
Research Site, Goettingen, , Germany
Research Site, Heidelberg, , Germany
Research Site, Homburg, , Germany
Research Site, Koeln, , Germany
Institute of Hematology and Medical Oncology "L. & A. Seràgnoli", Bologna, , Italy
O.U. di Clinica Ematologica, Genova, , Italy
Ospedale Policlinico S. Matteo, Pavia, , Italy
Dipartimento di Oncologia dei Trapianti e delle Nuove Tecnologie in Medicina, Roma, , Italy
Azienda Sanitaria Ospedaliera San Giovanni Battista (Molinette),, Torino, , Italy
Hospital Clinic I Provincial, Servicio de Hematologia, Barcelona, , Spain
Hospital Clinicio San Carlos, Servivio de Hematologia Clinica, Madrid, , Spain
Hospital Universitario 12 de Octubre,, Madrid, , Spain
Hospital Universitario Virgen de la Victoria, Servicio de oncologia, Malaga, , Spain
Clinica Universitaria de Navarra, Pamplona, , Spain
Complexo Hospitalario de Pontevedra Oncology Department, Pontevedra, , Spain
Hospital Clinico Universitario de Salamanca, Servicio de Hematologia, Salamanca, , Spain
Research Site, Valencia, , Spain
Somers Cancer Research Building, Southampton, , United Kingdom
Royal Marsden Hospital NHS Foundation Trust London and Surrey, Surrey, , United Kingdom
Medical Oncology, Christie Hospital NHS Trust, Withington, , United Kingdom
Name: Lei Zhang, MD
Affiliation: Celgene Corporation
Role: STUDY_DIRECTOR